{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:03:08Z","timestamp":1780077788579,"version":"3.54.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1U24HL135881"],"award-info":[{"award-number":["1U24HL135881"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Hydroxyurea is a vital medication for managing Sickle cell disease, yet access and adherence remain significant challenges in low-resource settings. This qualitative study explored challenges and opportunities in hydroxyurea access and adherence among Sickle cell disease patients at the Komfo Anokye Teaching Hospital in Ghana. Alongside, the utility of the Ahodwo CommCare mobile App in enhancing Sickle cell disease management was explored. Semi-structured interviews were conducted with six healthcare providers, including doctors, nurses, and pharmacists from May 12 to August 15, 2022. This study found that the key barriers to hydroxyurea access and adherence include financial constraints, medication stock-outs, administrative inefficiencies, bureaucratic delays, patient-related factors such as forgetfulness and concerns about side effects, and practical challenges in administering the medication especially to children. The healthcare workers indicated that reconstituting the medication into suspension added both cost and time constraints to children who cannot take capsules hence affecting access to hydroxyurea. Facilitators to access and adherence identified included patient education, streamlined procurement processes, and government support for medication subsidies. This study found that patient education sessions should emphasize the benefits of hydroxyurea treatment and the importance of adherence to prescribed regimens. The study also revealed limited awareness and utilization of the Ahodwo CommCare app among healthcare personnel, highlighting the need for targeted training and integration into clinical workflows. These findings underscore the importance of multifaceted interventions involving healthcare workers, hospital management, and government stakeholders to improve hydroxyurea access and adherence, ultimately enhancing Sickle cell disease patient outcomes.<\/jats:p>","DOI":"10.1371\/journal.pone.0347848","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:23:53Z","timestamp":1780075433000},"page":"e0347848","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Challenges and opportunities in hydroxyurea access and adherence for sickle cell disease patients at Komfo Anokye Teaching Hospital: Insights from healthcare providers"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3618-4860","authenticated-orcid":true,"given":"Josephine","family":"Mensah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afia Frimpomaa Asare","family":"Marfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercy Naa Aduele","family":"Opare-Addo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Obeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos","family":"Amoako-Adusei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Osei","family":"Afoduo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0484-8561","authenticated-orcid":true,"given":"Bright Ansah","family":"Adjei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2302-1854","authenticated-orcid":true,"given":"Pauline Boachie","family":"Ansah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwame Ohene","family":"Buabeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"2","key":"pone.0347848.ref001","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1182\/blood-2016-09-702324","article-title":"Sickle cell anemia in sub-Saharan Africa: advancing the clinical paradigm through partnerships and research","volume":"129","author":"PT McGann","year":"2017","journal-title":"Blood"},{"issue":"6","key":"pone.0347848.ref002","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2471\/BLT.06.036673","article-title":"Global epidemiology of haemoglobin disorders and derived service indicators","volume":"86","author":"B Modell","year":"2008","journal-title":"Bull World Health Organ"},{"issue":"9861","key":"pone.0347848.ref003","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"FB Piel","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"pone.0347848.ref004","doi-asserted-by":"crossref","first-page":"021103","DOI":"10.7189\/jogh.08.021103","article-title":"The global burden of sickle cell disease in children under five years of age: a systematic review and meta-analysis","volume":"8","author":"E Wastnedge","year":"2018","journal-title":"J Glob Health"},{"issue":"3","key":"pone.0347848.ref005","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/ajh.21968","article-title":"Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease","volume":"86","author":"SD Candrilli","year":"2011","journal-title":"Am J Hematol"},{"issue":"11","key":"pone.0347848.ref006","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/pbc.25608","article-title":"Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment","volume":"62","author":"PQ L\u00ea","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"pone.0347848.ref007","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/MOH.0000000000000582","article-title":"Effective use of hydroxyurea for sickle cell anemia in low-resource countries","volume":"27","author":"A Power-Hays","year":"2020","journal-title":"Curr Opin Hematol"},{"issue":"4","key":"pone.0347848.ref008","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MPH.0b013e3182114c54","article-title":"Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea","volume":"33","author":"CD Thornburg","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"issue":"12","key":"pone.0347848.ref009","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2009-05-221333","article-title":"The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)","volume":"115","author":"E Voskaridou","year":"2010","journal-title":"Blood"},{"issue":"10","key":"pone.0347848.ref010","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"BP Yawn","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"pone.0347848.ref011","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12288-013-0261-4","article-title":"Hydroxyurea in sickle cell disease: drug review","volume":"30","author":"RK Agrawal","year":"2014","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"4","key":"pone.0347848.ref012","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1590\/1516-3180.2013.1314467","article-title":"Clinical and hematological effects of hydroxyurea therapy in sickle cell patients: a single-center experience in Brazil","volume":"131","author":"AC Silva-Pinto","year":"2013","journal-title":"Sao Paulo Med J"},{"issue":"6","key":"pone.0347848.ref013","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/ejh.12878","article-title":"Barriers to hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease","volume":"98","author":"SM Badawy","year":"2017","journal-title":"Eur J Haematol"},{"issue":"9","key":"pone.0347848.ref014","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ajh.22101","article-title":"Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease","volume":"86","author":"AM Brandow","year":"2011","journal-title":"Am J Hematol"},{"issue":"1","key":"pone.0347848.ref015","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ajh.21883","article-title":"Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease","volume":"86","author":"Jr Haywood C","year":"2011","journal-title":"Am J Hematol"},{"issue":"4","key":"pone.0347848.ref016","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/jpepsy\/jsv084","article-title":"Systematic and Meta-Analytic Review: Medication Adherence Among Pediatric Patients With Sickle Cell Disease","volume":"41","author":"K Loiselle","year":"2016","journal-title":"J Pediatr Psychol"},{"issue":"6","key":"pone.0347848.ref017","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1542\/peds.2014-0177","article-title":"Medication adherence among pediatric patients with sickle cell disease: a systematic review","volume":"134","author":"KE Walsh","year":"2014","journal-title":"Pediatrics"},{"issue":"5","key":"pone.0347848.ref018","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"L Osterberg","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"pone.0347848.ref019","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038685","article-title":"Implementation of the therapeutic use of hydroxyurea for sickle cell disease management in resource-constrained settings: a systematic review of adoption, cost and acceptability","volume":"10","author":"N Ryan","year":"2020","journal-title":"BMJ Open"},{"issue":"4","key":"pone.0347848.ref020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11904-012-0134-8","article-title":"A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs","volume":"9","author":"MC Binford","year":"2012","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"6","key":"pone.0347848.ref021","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/jpepsy\/jst032","article-title":"A multicomponent motivational intervention to improve adherence among adolescents with poorly controlled type 1 diabetes: a pilot study","volume":"38","author":"C Stanger","year":"2013","journal-title":"J Pediatr Psychol"},{"issue":"7","key":"pone.0347848.ref022","doi-asserted-by":"crossref","DOI":"10.2196\/10940","article-title":"Patient-Centered eHealth Interventions for Children, Adolescents, and Adults With Sickle Cell Disease: Systematic Review","volume":"20","author":"SM Badawy","year":"2018","journal-title":"J Med Internet Res"},{"issue":"3","key":"pone.0347848.ref023","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jamainternmed.2015.7667","article-title":"Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis","volume":"176","author":"J Thakkar","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"5","key":"pone.0347848.ref024","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s13187-017-1200-0","article-title":"Examining the Impact of a Web-Based Intervention to Promote Patient Activation in Chemotherapy-Induced Peripheral Neuropathy Assessment and Management","volume":"33","author":"R Knoerl","year":"2018","journal-title":"J Cancer Educ"},{"key":"pone.0347848.ref025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2017.02.062","article-title":"Text Message Intervention (TEACH) Improves Quality of Life and Patient Activation in Celiac Disease: A Randomized Clinical Trial","volume":"185","author":"K Haas","year":"2017","journal-title":"J Pediatr"},{"issue":"5","key":"pone.0347848.ref026","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/pbc.25905","article-title":"Technology Access and Smartphone App Preferences for Medication Adherence in Adolescents and Young Adults With Sickle Cell Disease","volume":"63","author":"SM Badawy","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"pone.0347848.ref027","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.24483","article-title":"Barriers and facilitators to research participation among adults, and parents of children with sickle cell disease: A trans-regional survey","volume":"91","author":"RM Cronin","year":"2016","journal-title":"Am J Hematol"},{"key":"pone.0347848.ref028","unstructured":"Komfo Anokye Teaching Hospital. Komfo Anokye Teaching Hospital. https:\/\/kath.gov.gh\/about-us\/ 2024."},{"key":"pone.0347848.ref029","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.HS9.0000872940.76494.9b","article-title":"Identifying barriers to access to treatment with hydroxyurea for patients with sickle cell disease\u2013a qualitative analysis of the supply chain in Ghana","volume":"6","author":"S Graven","year":"2022","journal-title":"Hemasphere"},{"key":"pone.0347848.ref030","doi-asserted-by":"crossref","first-page":"921432","DOI":"10.3389\/fgene.2022.921432","article-title":"Barriers to hydroxyurea use from the perspectives of providers, individuals with sickle cell disease, and families: Report from a U.S. regional collaborative","volume":"13","author":"MJ Treadwell","year":"2022","journal-title":"Front Genet"},{"issue":"8","key":"pone.0347848.ref031","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1182\/bloodadvances.2019001142","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults","volume":"4","author":"MR DeBaun","year":"2020","journal-title":"Blood Adv"},{"key":"pone.0347848.ref032","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2147\/PPA.S137263","article-title":"The mediatory role of medication adherence in improving patients\u2019 medication experience through patient-physician communication among older hypertensive patients","volume":"11","author":"W Lee","year":"2017","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"pone.0347848.ref033","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ajh.21883","article-title":"Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease","volume":"86","author":"Jr Haywood C","year":"2011","journal-title":"Am J Hematol"},{"issue":"1","key":"pone.0347848.ref034","first-page":"44","article-title":"Hydroxyurea use among sickle cell patients in Ghana: Lessons from the Ahodwo Program","volume":"57","author":"C Segbefia","year":"2023","journal-title":"Ghana Medical Journal"},{"issue":"8","key":"pone.0347848.ref035","first-page":"1050","article-title":"Cost-effectiveness of hydroxyurea therapy for sickle cell disease management in sub-Saharan Africa","volume":"35","author":"OC Oluwole","year":"2020","journal-title":"Health Policy and Planning"},{"key":"pone.0347848.ref036","first-page":"1015789","article-title":"Pharmacy-based interventions for sickle cell disease management in sub-Saharan Africa","volume":"13","author":"BJ Brown","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"5","key":"pone.0347848.ref037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0003128","article-title":"Procurement process and shortages of essential medicines in public health facilities: A qualitative study from Nepal","volume":"4","author":"B Adhikari","year":"2024","journal-title":"PLOS Glob Public Health"},{"key":"pone.0347848.ref038","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1182\/blood-2023-188652","article-title":"Availability and cost of basic drugs for sickle cell disease in 13 African countries","volume":"142","author":"GK Keza","year":"2023","journal-title":"Blood"},{"issue":"1","key":"pone.0347848.ref039","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40545-022-00413-3","article-title":"Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan","volume":"15","author":"Z-U-D Babar","year":"2022","journal-title":"J Pharm Policy Pract"},{"key":"pone.0347848.ref040","doi-asserted-by":"crossref","first-page":"2055207620907187","DOI":"10.1177\/2055207620907187","article-title":"Physician attitudes towards-and adoption of-mobile health","volume":"6","author":"T Kong","year":"2020","journal-title":"Digit Health"},{"issue":"1","key":"pone.0347848.ref041","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12984-024-01431-9","article-title":"Exploring the perspectives of health care professionals on digital health technologies in pediatric care and rehabilitation","volume":"21","author":"I Roy","year":"2024","journal-title":"J Neuroeng Rehabil"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0347848","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:23:58Z","timestamp":1780075438000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0347848"}},"subtitle":[],"editor":[{"given":"Tomasz W.","family":"Kaminski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0347848","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]}}}